Christine Rojas

629 total citations
24 papers, 109 citations indexed

About

Christine Rojas is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Christine Rojas has authored 24 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Christine Rojas's work include Multiple Myeloma Research and Treatments (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Christine Rojas is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Christine Rojas collaborates with scholars based in Chile, United States and Argentina. Christine Rojas's co-authors include Yovanni Casablanca, Lawrence S. Amesse, Malcolm J. D’Souza, Harry J. Khamis, Nicholas W. Bateman, Thomas P. Conrads, Kathleen M. Darcy, Camila Peña, G. Larry Maxwell and Andreas Hochhaus and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gynecologic Oncology.

In The Last Decade

Christine Rojas

20 papers receiving 101 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine Rojas Chile	6	37	27	21	21	21	24	109
Valerie Blair United Kingdom	7	12 0.3×	28 1.0×	20 1.0×	15 0.7×	30 1.4×	7	126
Tomasz Jarmoliński Poland	7	25 0.7×	13 0.5×	12 0.6×	4 0.2×	11 0.5×	22	119
Marion E. van Hoorn Netherlands	4	98 2.6×	8 0.3×	8 0.4×	156 7.4×	26 1.2×	6	241
Carlos R. Torres‐Cintrón Puerto Rico	8	25 0.7×	64 2.4×	7 0.3×	8 0.4×	23 1.1×	24	144
Tomasz Ociepa Poland	8	43 1.2×	32 1.2×	7 0.3×	2 0.1×	49 2.3×	28	136
Inmaculada Soto Spain	9	187 5.1×	21 0.8×	33 1.6×	56 2.7×	3 0.1×	28	257
Anupama Rambhatla United States	8	10 0.3×	43 1.6×	3 0.1×	101 4.8×	68 3.2×	11	209
Lalit Mohan Sharma India	8	21 0.6×	33 1.2×	9 0.4×	3 0.1×	5 0.2×	28	145
Francesco Clemente Italy	7	6 0.2×	32 1.2×	10 0.5×	3 0.1×	5 0.2×	19	120
Frances B. Maguire United States	8	10 0.3×	78 2.9×	4 0.2×	10 0.5×	58 2.8×	23	171

Countries citing papers authored by Christine Rojas

Since Specialization

Citations

This map shows the geographic impact of Christine Rojas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Rojas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Rojas more than expected).

Fields of papers citing papers by Christine Rojas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Rojas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Rojas. The network helps show where Christine Rojas may publish in the future.

Co-authorship network of co-authors of Christine Rojas

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Rojas. A scholar is included among the top collaborators of Christine Rojas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Rojas. Christine Rojas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Johnson, Kirk W., Christine Rojas, Ludovic Muller, et al.. (2025). Application of preclinical absorption, distribution, metabolism, elimination in vitro techniques for the characterization and compound library optimization of novel antibiotic gallium salophen. Drug Metabolism and Disposition. 53(6). 100080–100080.

2.

Hunt, Allison L., Kelly A. Conrads, Brian L. Hood, et al.. (2022). Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment. Journal of Visualized Experiments. 2 indexed citations

3.

Bateman, Nicholas W., Christine Rojas, Kelly A. Conrads, et al.. (2022). Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues. Clinical Proteomics. 19(1). 35–35. 4 indexed citations

4.

Cabrera, María Elena, et al.. (2022). Diffuse Large B-Cell Lymphoma in Chile: The Impact of Combined CHOP Plus Rituximab in the Public Health System. JCO Global Oncology. 8(8). e2200165–e2200165. 1 indexed citations

5.

Yáñez, Eduardo, Christine Rojas, Anna Sureda, et al.. (2022). Pegathor Lymphoma, a Phase 2 Study of SAR444245 As a Monotherapy or in Combination with Pembrolizumab for the Treatment of Adults and Adolescents with Relapsed or Refractory B Cell Lymphoma. Blood. 140(Supplement 1). 12020–12021. 1 indexed citations

6.

Hunt, Allison L., Kelly A. Conrads, Brian L. Hood, et al.. (2022). Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment. Journal of Visualized Experiments. 1 indexed citations

7.

Rojas, Christine, Camila Peña, Rodrigo Valenzuela, et al.. (2021). Características clínicas y epidemiológicas de las neoplasias mieloproliferativas Philadelphia negativas en el sistema público de salud de Chile. Revista médica de Chile. 149(11). 1532–1538.

8.

Rojas, Christine, Chunqiao Tian, Matthew A. Powell, et al.. (2020). Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival. Gynecologic Oncology. 157(1). 67–77. 19 indexed citations

9.

Rojas, Christine, et al.. (2020). A seven-step surgical strategy for robotic splenectomy. International Journal of Gynecological Cancer. 30(7). 1079–1080. 1 indexed citations

10.

Paiva, Bruno, Irene Manrique, Nicola Giuliani, et al.. (2020). Prognostic Importance of Measurable Residual Disease (MRD) Kinetics and Progression-Free Survival (PFS) Benefit in MRD+ Patients (Pts) with Ixazomib Vs Placebo As Post-Induction Maintenance Therapy: Results from the Multicenter, Double-Blind, Phase 3 TOURMALINE-MM4 Trial in Non-Transplant Newly Diagnosed Multiple Myeloma (NDMM) Pts. Blood. 136(Supplement 1). 20–21. 1 indexed citations

11.

Beltrán, Brady, Camila Peña, Pilar León, et al.. (2019). Serum Albumin Is an Independent Factor Predicting Survival in Patients with Peripheral T Cell Lymphoma: A Multi-Institutional Study from the Latin American Working Group for Lymphomas (GELL). Blood. 134(Supplement_1). 4047–4047. 3 indexed citations

12.

Rojas, Christine & Yovanni Casablanca. (2019). Chemotherapy, Biologic, and Immunotherapy Breakthroughs in Cancer Care. Obstetrics and Gynecology Clinics of North America. 46(1). 137–154. 4 indexed citations

13.

Peña, Camila, et al.. (2019). AL amyloidosis in the Chilean public health system: a pending debt. Multicenter study of the Chilean Monoclonal Gammopathies Cooperative Group. Revista médica de Chile. 147(10). 1239–1246. 5 indexed citations

14.

Peña, Camila, et al.. (2019). Mieloma múltiple en Chile: Respuesta a tratamiento en pacientes con mieloma múltiple elegibles para trasplante autólogo de progenitores hematopoyéticos. Revista médica de Chile. 147(12). 1561–1568. 4 indexed citations

15.

Peña, Camila, Christine Rojas, Pilar León, et al.. (2019). Identifying a Simple Clinical Prognostic Model for Aggressive Adult T-Cell Leukemia/Lymphoma in Latin American Population and Its Validation: A Large International Study of the Latin America Working Group for Lymphomas (GELL). Blood. 134(Supplement_1). 4045–4045.

16.

Riva, Eloísa, Camila Peña, Guillermo J. Ruíz‐Argüelles, et al.. (2018). Significant Differences in Test Availability and Access to Novel Drugs for Multiple Myeloma between Public and Private Hospitals in Latin America. Grupo De Estudio Latinoamericano De Mieloma Multiple (GELAMM). Blood. 132(Supplement 1). 2244–2244. 3 indexed citations

17.

Peña, Camila, et al.. (2018). Mieloma múltiple en Chile: pasado, presente y futuro del programa nacional de drogas antineoplásicas (PANDA). Revisión de 1.103 pacientes. Revista médica de Chile. 146(7). 869–875. 8 indexed citations

18.

Rojas, Christine, Camila Peña, María Elena Cabrera, et al.. (2018). Characterization of Philadelphia-Negative Myeloproliferative Neoplasms in the Chilean Public Health System: Multicentric Study. Blood. 132(Supplement 1). 5479–5479. 1 indexed citations

19.

D’Souza, Malcolm J., et al.. (2015). Effect Of Gender And Lifestyle Behaviors On BMI Trends In A Sample Of The First State’s Undergraduate Population. PubMed. 6(1). 59–74. 17 indexed citations

20.

Rojas, Christine, et al.. (2013). Analysis of Patterns of Patient Compliance After an Abnormal Pap Smear Result. Journal of Lower Genital Tract Disease. 17(3). 298–302. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact